ViCentra announced today that it began commercial-scale production of its Kaleido insulin pump technology at Phillips Medisize. The Dutch automated insulin delivery system developer said it began production of consumables, including infusion sets and insulin cartridges, with the Molex company — a leading global medical technology contract development and manufacturing organization (CDMO). The collaboration more […]
Drug-Device Combinations
Abbott wins CE mark for dual glucose-ketone sensor
Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people with diabetes. The company said its dual sensor marks a world first, continuously measuring glucose and ketone levels every minute. Branded as Libre Duo and Libre Duo 10 Day, the sensors provide real-time visibility into glucose levels […]
Insulet initiates another Omnipod 5 recall affecting 7 million devices including some Dash, Eros systems
Insulet (Nasdaq:PODD) today announced a voluntary medical device correction for specific lots of its Omnipod 5, Dash and Eros pods. The company identified a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery with the affected current-generation Omnipod 5, previous-generation Omnipod Dash or the prior Omnipod Insulin Management System (Eros). Insulet said […]
MiniMed launches MiniMed Go smart multiple daily injection system in US
MiniMed (Nasdaq:MMED) announced today that it began the U.S. launch of MiniMed Go, a connected smart multiple daily injection (MDI) system. The smart MDI system integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within a mobile app to deliver real-time, personalized insights and actionable guidance. The platform targets people […]
Tandem launches t:slim mobile app in trio of European countries
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its t:slim mobile app available in a handful of new European countries. The company said on LinkedIn via its International account that it made the app available on both Android and iOS in Germany, Belgium and the Netherlands. San Diego-based Tandem’s t:slim mobile app connects to […]
Beta Bionics earmarks Q2 2027 for Mint patch pump launch, shares details on new tech
Beta Bionics (Nasdaq:BBNX) today provided an update on its expected commercialization timeline for its Mint patch pump system. Irvine, California-based Beta Bionics said it expects to fully commercialize Mint by the end of the second quarter of 2027. This represents an accelerated timeline compared to previous expectations for the end of 2027. The automated insulin […]
New data backs MiniMed 780G pump, SmartGuard algorithm across CGM types
MiniMed (Nasdaq:MMED) today shared findings from a new randomized crossover study backing the use of its 780 automated insulin pump. Findings demonstrated virtually identical glycemic outcomes for users of the pump across two different continuous glucose monitors (CGMs). Investigators published data today in Diabetes Technology & Therapeutics. MiniMed says outcomes reinforce that its automated insulin […]
Reflow Medical has positive data for coronary drug-eluting stent
Reflow Medical today announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its stent system to transfer a proprietary drug formulation to the diseased lesion without leaving a permanent metallic implant behind. The device’s retrievable scaffold therapy creates channels to increase the […]
MiniMed has a new board member following Brett Wall’s Medtronic departure
MiniMed (Nasdaq:MMED) announced the appointment of Scott Cundy to its board of directors, effective July 3, 2026. Cundy’s appointment comes in the wake of Brett Wall’s departure from MiniMed parent company, Medtronic, announced this week. Wall, the EVP and president of the Medtronic Neuroscience portfolio, served as a class II director for MiniMed and as […]
Elixir Medical study backs DynamX bioadaptor against drug-eluting stent
Elixir Medical today announced four-year results from a study comparing its DynamX coronary bioadaptor system to a leading drug-eluting stent (DES). The BIOADAPTOR randomized controlled trial compared DynamX to the Medtronic Resolute Onyx DES, the current standard of care. It compared the therapies across Japan, Europe and New Zealand. Investigators shared findings from 445 patients […]
